Efficacy and safety of HDACIs in the treatment of metastatic or unresectable renal cell carcinoma with a clear cell phenotype: A systematic review and meta-analysis

BACKGROUND: In this study, we evaluated the efficacy and safety of histone deacetylase inhibitors (HDACIs) in the treatment of renal cell carcinoma (RCC). METHODS: PubMed, EMBASE, the Cochrane Library, CNKI, and the Wanfang database were searched to retrieve studies describing the use of HDACIs for...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Juan, Ren, Jia-Ju, Cai, Jiangxia, Wang, Xiaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341361/
https://www.ncbi.nlm.nih.gov/pubmed/34397830
http://dx.doi.org/10.1097/MD.0000000000026788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8341361/
https://www.ncbi.nlm.nih.gov/pubmed/34397830
http://dx.doi.org/10.1097/MD.0000000000026788

Ejemplares similares